• TRAP-1 Reactivates p53Y220C Through Induced Proximity

  2026-09-08

  The bioRxiv preprint reports TRAP-1, a chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4 and restores transcriptional activity. In p53Y220C-expressing pancreatic cell lines, this mechanism rapidly induced p21 and other p53 target genes while suppressing cell growth, whereas control compounds unable to form the ternary complex lacked these effects.

• Merimepodib (VX-497): Practical IMPDH Workflows

  2026-09-07

  Merimepodib (VX-497) enables controlled interrogation of guanine-nucleotide metabolism in antiviral, immunology, and oncology assays. This guide translates IMPDH biology and recent PEDV findings into practical dosing, rescue, readout, and troubleshooting strategies.

• Methylprednisolone Workflows for Inflammation Models

  2026-09-07

  Methylprednisolone provides a controlled glucocorticoid perturbation for cytokine, macrophage, and bone-injury studies. This guide connects in vitro anti-inflammatory assays with a glucocorticoid-induced osteonecrosis workflow while emphasizing formulation control, orthogonal endpoints, and practical troubleshooting.

• BCECF-AM for Intracellular pH Measurement

  2026-09-05

  BCECF-AM is a cell membrane permeable dye and intracellular esterase substrate used for ratiometric intracellular pH measurement. Its 490/440 excitation approach can report pH-sensitive fluorescence, but plant vacuolar acidification requires compartment-specific validation.

• PEDV Hijacks IMPDH-Dependent Nucleotide Biosynthesis

  2026-09-04

  Zhou and colleagues show that porcine epidemic diarrhea virus (PEDV) reprograms host purine metabolism and depends on IMPDH2-driven guanine nucleotide biosynthesis for efficient replication. By combining comparative metabolomics, IMPDH2 knockdown, and Merimepodib (VX-497) treatment, the study identifies IMPDH as a plausible host-directed antiviral target while also highlighting cell-specific metabolic responses.

• Cisapride (R 51619) for Cardiac Safety Workflows

  2026-09-04

  Cisapride (R 51619) provides a practical bridge between 5-HT4 receptor pharmacology and hERG channel inhibition in cardiac electrophysiology research. This workflow shows how to combine iPSC-derived cardiomyocytes, high-content imaging, and targeted electrophysiology to distinguish useful phenotypic signals from assay artifacts.

• Dabigatran Etexilate: Reading Thrombin Assays

  2026-09-03

  Dabigatran etexilate is a direct thrombin inhibitor and oral prodrug used in anticoagulant research. This guide focuses on a frequently overlooked question: how prodrug activation, assay matrix, and endpoint selection shape the interpretation of thrombin-inhibition data.

• GSK 2837808A: From LDHA Flux to Immune Signaling

  2026-09-03

  GSK 2837808A is a selective lactate dehydrogenase A inhibitor for separating glycolytic flux from downstream tumor signaling. This article develops an assay strategy that connects lactate reduction and glucose consumption reduction to the NAT1–ENO1–lactate–PD-L1 pathway without overstating preclinical evidence.

• Foretinib: From Kinase Potency to Translational Signal

  2026-09-02

  Foretinib (GSK1363089) is more than a potent multikinase reagent: it is a strategic tool for linking Met and VEGFR pathway biology with interpretable measurements of proliferation, motility, invasion, and metastasis. This thought-leadership guide shows translational researchers how to pair its mechanistic breadth with endpoint-aware assay design, orthogonal validation, and disciplined interpretation of preclinical models.

• SHC-1 Control of CFTR Surface Abundance

  2026-09-02

  The reference study shows that MAPK/SHC-1-dependent internalization of CFTR is conserved across airway and intestinal epithelial models, while the response to SHC-1 inhibition is strongly cell-type dependent. Its principal contribution is to separate pathway conservation from intervention specificity, highlighting why plasma-membrane abundance must be assessed alongside unrelated surface proteins.

• IAM-LC and LEKC for Pulmonary Permeability

  2026-09-01

  The reference study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for biomimetic drug–membrane partitioning. Its results show that LEKC more closely represented apparent pulmonary permeability, whereas IAM-LC offered broader compound coverage, simpler operation, and stronger potential for automated screening.

• NAT1–ENO1–Lactate Signaling in Colorectal Cancer

  2026-09-01

  A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator that restrains ENO1 activity, lactate production, and TRAF6-dependent PD-L1 stabilization in colorectal cancer. The findings provide a preclinical framework for testing lactate-pathway perturbation alongside immune checkpoint blockade, while emphasizing that the proposed mechanism still requires pharmacological and clinical validation.

• FGFR–TGFβ–PI3K/AKT Control of Periostin

  2026-08-31

  Labrèche et al. identify a signaling cross talk that controls periostin expression in Neu-positive breast cancer models, linking FGFR, TGFβ, PKC, and PI3K/AKT activity. The study distinguishes stromal constitutive expression from epithelial tumor-cell acquisition of periostin and provides a framework for interpreting context-dependent extracellular-matrix regulation.

• NMDA for Glaucoma Excitotoxicity Research

  2026-08-31

  NMDA provides a direct, controllable way to model receptor-driven calcium overload, oxidative stress, and retinal ganglion cell injury. This workflow connects excitotoxicity research with ferroptosis-focused readouts and BMP4-GPX4 rescue experiments in glaucoma models.

• Heparin Sodium as a Mechanistic HSPG Control

  2026-08-30

  Heparin sodium is a glycosaminoglycan anticoagulant best known for antithrombin activation, but its polyanionic structure also makes it a valuable control for heparan sulfate proteoglycan-dependent uptake studies. This article develops a practical framework for interpreting coagulation assays and nanovesicle experiments without conflating established evidence with emerging hypotheses.

8532 records 6/569 page Previous Next First page 上5页 678910 下5页 Last page